http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01309677-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-24 |
filingDate | 1988-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809882d993b44ced11f8230156674923 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71f638cad9ada4ce335718cb3b7478ce |
publicationDate | 1989-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H01309677-A |
titleOfInvention | Microorganism |
abstract | NEW MATERIAL:Rhodococcus espi M-750 (FERM P-9946) having end type glycolipid-decomposing enzyme-producing ability in the absence of glycolipid. USE:Useful in determination of structure of virus receptor of cell surface layer, specific cancer antigen, etc. PREPARATION:Phodococcus espi G-74 (FERM P-8424) collected from a soil in MACHIDA city, TOKYO prefecture is cultured and then collected. Then the bacterium is suspended in an aqueous solution of common salt subjected to sterilization treatment and is subjected to variation treatment by ultraviolet irradiation. Further, the bacterium is cultured in an equine blood agar medium to select and collect a variant strain forming no transparent ring and then the cultured variant strain is subjected to variant treatment with a nitroguanidine-containing acetic acid buffer solution. |
priorityDate | 1988-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.